Ageing in rare, chronic diseases
نویسنده
چکیده
With more and more treatments becoming available for people with rare diseases, we encounter the issue of ageing more often. A number of patients with rare, chronic diseases have experienced a number of remarkable transitions in their lives. The most important transition is the one from no treatment at all to treatment becoming available, like in haemophilia about 45 years ago. Another transition is the one that during their lives they go from one disease to a number of diseases (co-morbidity) through the natural process of getting older or as a consequence of the side-effects of treatment. These transitions can cause a number of problems. The first problem could be the lack of co-ordination between medical specialists and paramedical staff. The second is polypharmacy the use of multiple medications and as a consequence of these first two problems a third problem occurs which I prefer to address as the ‘fear’ factor. The ‘fear’ factor can be described as a lack of control when you are not able to influence or check the treatment you receive. When more and more older persons with rare, chronic diseases will gradually transit to special care institutions for the elderly, more knowledge should be available in these institutions to deal with these new groups of patients. In this way, these patients will differ a lot from the group of elderly persons who develop comorbidity at a much older age. Some of these issues will be addressed in this presentation, based on the personal experience of the speaker, who is also the (co-)author of several recent books on getting older with chronic diseases, like haemophilia and HIV. Published: 19 October 2010
منابع مشابه
Ageing and the border between health and disease.
Ageing is associated with a progressive degeneration of the tissues, which has a negative impact on the structure and function of vital organs and is among the most important known risk factors for most chronic diseases. Since the proportion of the world's population aged >60 years will double in the next four decades, this will be accompanied by an increased incidence of chronic age-related di...
متن کاملSevere muscle weakness during treatment with pegylated interferon alfa for chronic hepatitis C virus infection A rare complication
Background: Interferons (IFNs) are common therapeutics for several diseases such as viral hepatitis, multiple sclerosis and malignancy. A variety of autoimmune related side effects have been observed during IFN therapy. Rare cases of myopathy, polymyositis or dermatomyositis have been reported during therapy with high doses of IFN^5. Case Presentation: In this report, we describe a case with se...
متن کاملPhysical performance, sarcopenia and respiratory function in older patients with chronic obstructive pulmonary disease.
متن کامل
بررسی مقایسهای شاخصهای سلامت سالمندان در دوگروه سنی 64-60 و69-65 سال در شهرتهران
Introduction: Studying of physical and mental health of older adults is important for health care services to elderly. With increasing ageing population and chronic diseases among older people, the expenditure of ageing services will increase. Thus, it is necessary to clear a cut point chronological age for starting ageing career. The aim of this paper is to understand health differences ...
متن کاملMechanisms of development of multimorbidity in the elderly.
In ageing populations many patients have multiple diseases characterised by acceleration of the normal ageing process. Better understanding of the signalling pathways and cellular events involved in ageing shows that these are characteristic of many chronic degenerative diseases, such as chronic obstructive pulmonary disease (COPD), chronic cardiovascular and metabolic diseases, and neurodegene...
متن کامل